3,507 results match your criteria Hepatoblastoma


Retrospective Analysis of Childhood Hepatoblastoma in a Single Centre in China.

Clin Oncol (R Coll Radiol) 2019 Apr 15. Epub 2019 Apr 15.

Department of Hematology/Oncology, Shanghai Children's Medical Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address:

Aims: To investigate the protocol efficacy and prognostic factors for paediatric hepatoblastoma in a multidisciplinary model in our centre.

Materials And Methods: Consecutive hepatoblastoma patients (<18 years old) treated at Shanghai Children's Medical Center in China from August 2011 to October 2017 were analysed retrospectively for clinical features, chemotherapy courses, surgical treatment and outcomes.

Results: One hundred and four cases of paediatric hepatoblastoma (64 males, 40 females; median age at diagnosis 1. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.clon.2019.03.044DOI Listing
April 2019
2 Reads

Fourier transform infrared and Raman-based biochemical profiling of different grades of pure foetal-type hepatoblastoma.

J Biophotonics 2019 Apr 16:e201800304. Epub 2019 Apr 16.

Institute of Reproductive Health, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

The biomolecular events resulting from the progression of hepatoblastoma remain to be elucidated. Fourier-transform infrared (FTIR) and Raman spectroscopies are capable of noninvasively and accurately capturing the biochemical properties of biological tissue from its pathological status. Our aim was to probe critial biomolecular changes of liver accompanying the progression of pure foetal hepatoblastoma (PFH) by FTIR and Raman spectroscopies. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/jbio.2018003
Publisher Site
http://dx.doi.org/10.1002/jbio.201800304DOI Listing
April 2019
1 Read

Experimental observation of mitochondrial oxidative damage of liver cells induced by isonicotinic acid hydrazide.

Exp Ther Med 2019 May 20;17(5):4289-4293. Epub 2019 Mar 20.

Key Laboratory of Occupational Health and Safety, School of Public Health, North China University of Science and Technology, Tangshan, Hebei 063000, P.R. China.

The aim of the present study was to investigate the oxidative damage of liver mitochondria as an adverse effect of the anti-tuberculosis drug isonicotinic acid hydrazide (INH). The human hepatoblastoma cell line (HepG2) was exposed to INH at concentrations of 0, 1, 2 or 4 mg/ml for 24, 48, 72 or 96 h, and the levels of malondialdehyde (MDA), superoxide dismutase (SOD), glutathione peroxidase (GSH-Px) and 8-hydroxy-2-deoxyguanosine (8-OHdG) in mitochondria were detected. Changes in the mitochondrial ultrastructure were observed by electron microscopy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/etm.2019.7417DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6447889PMC

Trends in International Incidence of Pediatric Cancers in Children Under 5 Years of Age: 1988-2012.

JNCI Cancer Spectr 2019 Mar 9;3(1):pkz007. Epub 2019 Apr 9.

Background: Pediatric cancer incidence has been steadily increasing over the last several decades with the largest increases reported in infants. Few evaluations have looked at international pediatric cancer incidence trends in the youngest children. The aim of this analysis was to evaluate trends in cancer incidence in children under 5 years of age, overall and by type, using data from () from 1988 to 2012 (CI5 volumes VII-XI). Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jncics/pkz007DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6455426PMC
March 2019
1 Read

Diagnostic Performance of 2-D Shear Wave Elastography for Differentiation of Hepatoblastoma and Hepatic Hemangioma in Children under 3 Years of Age.

Ultrasound Med Biol 2019 Apr 9. Epub 2019 Apr 9.

Department of Ultrasound, Beijing Friendship Hospital, Capital Medical University, Beijing 100050, China. Electronic address:

The aim of the present study was to prospectively evaluate the clinical efficiency of 2-D shear wave elastography (2-D-SWE) for differentiating hepatoblastoma and hepatic hemangioma in children under 3 y of age. 2-D-SWE was performed in 109 consecutive patients with confirmed hepatic neoplasms by pathologic analysis or contrast-enhanced computed tomography plus follow-up observation, in which 71 patients were defined as the test group, and the remaining 38 patients were defined as the validation group. An elasticity value was obtained from each lesion. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ultrasmedbio.2019.02.007DOI Listing
April 2019
1 Read

Characterization of pediatric hepatocellular carcinoma reveals genomic heterogeneity and diverse signaling pathway activation.

Pediatr Blood Cancer 2019 Apr 11:e27745. Epub 2019 Apr 11.

Department of Pathology and Immunology, Baylor College of Medicine, Houston, Texas.

Background: Pediatric hepatocellular carcinoma (HCC) is a rare liver tumor in children with a poor prognosis. Comprehensive molecular profiling to understand the underlying genomic drivers of this tumor has not been completed, and it is unclear whether nonfibrolamellar pediatric HCC is more genomically similar to hepatoblastoma or adult HCC.

Procedure: To characterize the molecular landscape of these tumors, we analyzed a cohort of 15 pediatric non-FL-HCCs by sequencing a panel of cancer-associated genes and conducting copy-number and gene-expression analyses. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1002/pbc.27745
Publisher Site
http://dx.doi.org/10.1002/pbc.27745DOI Listing
April 2019
7 Reads

Minimal adjuvant chemotherapy for children with hepatoblastoma resected at diagnosis (AHEP0731): a Children's Oncology Group, multicentre, phase 3 trial.

Lancet Oncol 2019 Apr 8. Epub 2019 Apr 8.

Primary Children's Hospital, Salt Lake City, UT, USA.

Background: Hepatoblastoma treatment with curative intent requires surgical resection, but only about a third of newly diagnosed patients with hepatoblastoma have resectable disease at diagnosis. Patients who have upfront resection typically receive a total of 4-6 cycles of adjuvant chemotherapy post-surgery, with the combination of cisplatin, fluorouracil, and vincristine. We aimed to investigate whether event-free survival in children with hepatoblastoma who had complete resection at diagnosis could be maintained with two cycles of adjuvant chemotherapy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(18)30895-7DOI Listing
April 2019
1 Read

Is it worth completely resecting hepatoblastoma at diagnosis?

Authors:
Piotr Czauderna

Lancet Oncol 2019 Apr 8. Epub 2019 Apr 8.

Department of Surgery and Urology for Children and Adolescents, Medical University of Gdansk, 80-210 Gdansk, Poland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1470-2045(19)30096-8DOI Listing

Focal nodular hyperplasia of the liver in children: A report of 2 cases.

Indian J Pathol Microbiol 2019 Apr-Jun;62(2):261-265

Department of Pathology, IPGME and R, Kolkata, West Bengal, India.

Focal nodular hyperplasia (FNH) is a benign non-neoplastic lesion of the liver usually found in adults. It is uncommon in children, comprising 2-10% of all pediatric liver tumours. In children, it can occur at all ages, with increased frequency between 6-10 years. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/IJPM.IJPM_396_18DOI Listing
April 2019
1 Read

PP2A activation alone and in combination with cisplatin decreases cell growth and tumor formation in human HuH6 hepatoblastoma cells.

PLoS One 2019 10;14(4):e0214469. Epub 2019 Apr 10.

Division of Pediatric Surgery, Department of Surgery, University of Alabama, Birmingham, Birmingham, AL, United States of America.

Despite an increase in incidence, treatments for hepatoblastoma remain virtually unchanged for the past 20 years, emphasizing the need for novel therapeutics. FTY720 (fingolimod) is an immunomodulator approved for use in multiple sclerosis in children that has been demonstrated to have anti-cancer properties in multiple cancer types. We have demonstrated that FTY720 activates PP2A in hepatoblastoma, but does not do so via inhibition of the endogenous inhibitors, CIP2A and I2PP2A, as previously observed in other cancers. Read More

View Article

Download full-text PDF

Source
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0214469PLOS
April 2019
1 Read

Central Hepatectomy (Mesohepatectomy) by Double Liver Hanging Maneuver (DLHM) in a Child with Hepatoblastoma.

Indian J Surg Oncol 2019 Mar 13;10(1):46-49. Epub 2018 Nov 13.

4Department of Pathology, Kidwai Memorial Institute of Oncology, Bangalore, India.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s13193-018-0823-xDOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6414566PMC

Use of a donor iliac vein graft for reconstruction of the inferior vena cava in liver transplantation for hepatoblastoma with caval extension.

Pediatr Transplant 2019 Apr 4:e13409. Epub 2019 Apr 4.

The Department of Surgery, The Children's Hospital Westmead, Part of the Sydney Children's Hospital Network, Westmead, New South Wales, Australia.

Complete microscopic tumor resection is critical for successful treatment of hepatoblastoma, and this may include when liver transplantation is required. For tumors involving the IVC or PV, complete resection should include the involved IVC or PV to ensure full tumor clearance. When this is required, the venous reconstruction at transplant or post-excision can be challenging. Read More

View Article

Download full-text PDF

Source
https://onlinelibrary.wiley.com/doi/abs/10.1111/petr.13409
Publisher Site
http://dx.doi.org/10.1111/petr.13409DOI Listing
April 2019
2 Reads

The Role of MicroRNAs in Hepatoblastoma Tumors.

Cancers (Basel) 2019 Mar 22;11(3). Epub 2019 Mar 22.

Translational Oncology Division, Oncohealth Institute, IIS-Fundación Jiménez Díaz-UAM, E-28040 Madrid, Spain.

Hepatoblastoma is the most common hepatic malignancy during childhood. However, little is still known about the molecular mechanisms that govern the development of this disease. This review is focused on the recent advances regarding the study of microRNAs in hepatoblastoma and their substantial contribution to improv our knowledge of the pathogenesis of this disease. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11030409DOI Listing

Mechanisms of Anticancer Drug Resistance in Hepatoblastoma.

Cancers (Basel) 2019 Mar 22;11(3). Epub 2019 Mar 22.

Experimental Hepatology and Drug Targeting (HEVEFARM), University of Salamanca, IBSAL, 37007 Salamanca, Spain.

The most frequent liver tumor in children is hepatoblastoma (HB), which derives from embryonic parenchymal liver cells or hepatoblasts. Hepatocellular carcinoma (HCC), which rarely affects young people, causes one fourth of deaths due to cancer in adults. In contrast, HB usually has better prognosis, but this is still poor in 20% of cases. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3390/cancers11030407DOI Listing
March 2019
1 Read

Congenital hepatoblastoma in a growing health economy.

BMJ Case Rep 2019 Mar 20;12(3). Epub 2019 Mar 20.

Neonatal Unit, Al Corniche Hospital, Abu Dhabi, United Arab Emirates.

A 43-year-old woman, whose pregnancy was complicated by the presence of a large single solid intra-abdominal fetal mass, was referred from the private sector into our fetal maternal unit at the Corniche Hospital, Abu Dhabi at 36 weeks postmenstrual age.Investigations subsequently confirmed that this mass was a congenital hepatoblastoma, one of the very rare embryonic tumours. The baby had chemotherapy and surgical excision of the tumour. Read More

View Article

Download full-text PDF

Source
http://casereports.bmj.com/lookup/doi/10.1136/bcr-2017-22334
Publisher Site
http://dx.doi.org/10.1136/bcr-2017-223344DOI Listing
March 2019
4 Reads

The presence of PIM3 increases hepatoblastoma tumorigenesis and tumor initiating cell phenotype and is associated with decreased patient survival.

J Pediatr Surg 2019 Feb 28. Epub 2019 Feb 28.

Department of Surgery, University of Alabama at Birmingham, Birmingham, AL. Electronic address:

Purpose: Hepatoblastoma is the most common primary liver cancer of childhood and has few prognostic indicators. We have previously shown that Proviral Integration site for Moloney murine leukemia virus (PIM3) kinase decreased hepatoblastoma tumorigenicity. We sought to determine the effect of PIM3 overexpression on hepatoblastoma cells and whether expression of PIM3 correlated with patient/tumor characteristics or survival. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00223468193017
Publisher Site
http://dx.doi.org/10.1016/j.jpedsurg.2019.02.029DOI Listing
February 2019
6 Reads

Hepatitis C virus nonstructural 5A protein inhibits the starvation‑induced apoptosis of hepatoblastoma cells by increasing Beclin 1 expression.

Oncol Rep 2019 May 13;41(5):3051-3059. Epub 2019 Mar 13.

Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, P.R. China.

Hepatitis C virus (HCV) nonstructural protein 5A (NS5A) modulates cellular apoptosis, which is involved in the occurrence and development of liver cancer. The mechanisms of apoptosis inhibition by NS5A in liver cancer cells remains unclear. Beclin 1, which functions upstream of autophagosome formation, is upregulated by NS5A. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2019.7060DOI Listing
May 2019
1 Read

LASS2 inhibits proliferation and induces apoptosis in HepG2 cells by affecting mitochondrial dynamics, the cell cycle and the nuclear factor‑κB pathways.

Oncol Rep 2019 May 13;41(5):3005-3014. Epub 2019 Mar 13.

Department of Clinical Laboratory, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563003, P.R. China.

LAG1 longevity assurance homolog 2 (LASS2) is a candidate biomarker in cancer that is dysregulated in various types of tumor, potentially affecting cell growth, invasion and migration. Although its effects on liver cancer metastasis and invasion have been reported, specific phenotypic studies and potential molecular mechanisms have not been completely elucidated in hepatoblastoma (HB). In the present study, the effect of LASS2 on the proliferation, apoptosis and cell cycle of HepG2 HB cells was assessed, and the underlying mechanisms were investigated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/or.2019.7058DOI Listing
May 2019
2 Reads

Arctigenin induces apoptosis in human hepatoblastoma cells.

Pediatr Surg Int 2019 Mar 19. Epub 2019 Mar 19.

Pediatric Surgery Department, Fujita Health University, Toyoake, Japan.

Purpose: Arctigenin has been shown to have anti-tumor effects in various types of cancers. This study was conducted to verify these effects in the human-derived hepatoblastoma cell line, HUH-6 clone 5 (hereinafter, HUH-6).

Methods: Arctigenin was added to cultured HUH-6 cells, and cellular activity was evaluated by MTS assay. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00383-019-04473-6DOI Listing

Isolated Silymarin Flavonoids Increase Systemic and Hepatic Bilirubin Concentrations and Lower Lipoperoxidation in Mice.

Oxid Med Cell Longev 2019 12;2019:6026902. Epub 2019 Feb 12.

Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University, Kateřinská 32, Praha 2 12000, Czech Republic.

Bilirubin is considered to be one of the most potent endogenous antioxidants in humans. Its serum concentrations are predominantly affected by the activity of hepatic bilirubin UDP-glucuronosyl transferase (UGT1A1). Our objective was to analyze the potential bilirubin-modulating effects of natural polyphenols from milk thistle (), a hepatoprotective herb. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1155/2019/6026902DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390243PMC
February 2019

Pure fetal hepatoblastoma in a young female.

Authors:
Yi Cao Chaoliu Dai

Hepatobiliary Surg Nutr 2019 Feb;8(1):85-86

Department of Hepatobiliary and Splenic Surgery, China Medical University, Shenyang 110004, China.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.21037/hbsn.2019.01.02DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6383018PMC
February 2019
1 Read

Immunotherapeutic Targeting of GPC3 in Pediatric Solid Embryonal Tumors.

Front Oncol 2019 26;9:108. Epub 2019 Feb 26.

Department of Pediatrics, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

Glypican 3 (GPC3) is a heparan sulfate proteoglycan and cell surface oncofetal protein which is highly expressed on a variety of pediatric solid embryonal tumors including the majority of hepatoblastomas, Wilms tumors, rhabdoid tumors, certain germ cell tumor subtypes, and a minority of rhabdomyosarcomas. Via both its core protein and heparan sulfate side chains, GPC3 activates the canonical Wnt/β-catenin pathway, which is frequently overexpressed in these malignancies. Loss of function mutations in lead to Simpson-Golabi-Behmel Syndrome, an X-linked overgrowth condition with a predisposition to GPC3-expressing cancers including hepatoblastoma and Wilms tumor. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3389/fonc.2019.00108DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6401603PMC
February 2019
4 Reads

Targeting excessive MYCN expression using MLN8237 and JQ1 impairs the growth of hepatoblastoma cells.

Int J Oncol 2019 May 5;54(5):1853-1863. Epub 2019 Mar 5.

Department of Pediatric Surgery, Dr. von Hauner Children's Hospital, University Hospital, LMU Munich, D‑80337 Munich, Germany.

Hepatoblastoma (HB) is the most common liver tumor in children under the age of 3 years worldwide. While many patients achieve good outcomes with surgical resection and conventional chemotherapy, there is still a high‑risk population that exhibits a poor treatment response and unfavorable prognosis, which warrants the search for novel treatment options. In recent years, it has become clear that genetic events alone are not sufficient to explain the aggressive phenotype of this embryonal malignancy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2019.4741DOI Listing
May 2019
1 Read

mTOR inhibition affects Yap1-β-catenin-induced hepatoblastoma growth and development.

Oncotarget 2019 Feb 19;10(15):1475-1490. Epub 2019 Feb 19.

Division of Experimental Pathology, Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.

Hepatoblastoma (HB) is the most common pediatric liver malignancy. Around 80% of HB demonstrate simultaneous activation of β-catenin and Yes-associated protein 1 (Yap1). The mechanism by which these signaling pathways contribute to HB pathogenesis remain obscure. Read More

View Article

Download full-text PDF

Source
http://www.oncotarget.com/fulltext/26668
Publisher Site
http://dx.doi.org/10.18632/oncotarget.26668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407673PMC
February 2019
6 Reads

Adult-to-adult living-donor liver transplantation: The experience of the Université catholique de Louvain.

Hepatobiliary Pancreat Dis Int 2019 Apr 28;18(2):132-142. Epub 2019 Feb 28.

Starzl Abdominal Transplant Unit, Cliniques Universitaires Saint-Luc, Institut de Recherche Expérimentale et Clinique, Université catholique de Louvain, Avenue Hippocrates 10, 1200 Brussels, Belgium. Electronic address:

Background: Liver transplantation is the treatment for end-stage liver diseases and well-selected malignancies. The allograft shortage may be alleviated with living donation. The initial UCLouvain experience of adult living-donor liver transplantation (LDLT) is presented. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hbpd.2019.02.007DOI Listing
April 2019
1 Read

Risk of selected childhood cancers and parental employment in painting and printing industries: A register-based case‒control study in Denmark 1968-2015.

Scand J Work Environ Health 2019 Mar 6. Epub 2019 Mar 6.

The Danish Cancer Society Research Center, Strandboulevarden 49, DK-2100 Copenhagen Ø, Denmark.

Objectives Parental exposures and offspring's risk of cancer have been studied with inconsistent results. We investigated parental employment in painting and printing industries and risk of childhood leukemia, central nervous system (CNS) cancers, and prenatal cancers (acute lymphoblastic leukemia, Wilms tumor, medulloblastoma, neuroblastoma, retinoblastoma, and hepatoblastoma). Methods Using Danish registries, children aged ≤19 years diagnosed from 1968-2015 with leukemia (N=1999), CNS cancers (N=1111) or prenatal cancers (N=2704) were linked to parents and their employment history one year before birth to birth for fathers, and one year before birth to one year after for mothers. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5271/sjweh.3811DOI Listing
March 2019
6 Reads

Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature.

Dig Dis 2019 Mar 5:1-6. Epub 2019 Mar 5.

Clinic for Gastroenterology and Hepatology, Clinical Center of Serbia, Belgrade, Serbia,

Hereditary polyposis syndromes in which APC gene germline mutations can lead to colorectal carcinogenesis are familial adenomatous polyposis (FAP), attenuated FAP (AFAP) and MUTYH-associated polyposis. All 3 syndromes increase the potential for the development of colorectal cancer. AFAP is diagnosed if less than 100 adenomas are detected in the colon at presentation. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000497207DOI Listing
March 2019
1 Read

[Chinese expert group consensus on pathological diagnosis of hepatoblastoma].

Authors:

Zhonghua Bing Li Xue Za Zhi 2019 Mar;48(3):176-181

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3760/cma.j.issn.0529-5807.2019.03.002DOI Listing
March 2019
2 Reads

Anacolosins A-F and Corymbulosins X and Y, Clerodane Diterpenes from Anacolosa clarkii Exhibiting Cytotoxicity toward Pediatric Cancer Cell Lines.

J Nat Prod 2019 Mar 4. Epub 2019 Mar 4.

Natural Products Branch, Developmental Therapeutics Program, Division of Cancer Treatment and Diagnosis , National Cancer Institute , Frederick , Maryland 21702 , United States.

An extract of the plant Anacolosa clarkii was obtained from the NCI Natural Products Repository, and it showed cytotoxic activity toward several types of pediatric solid tumor cell lines. Bioassay-guided fractionation led to the purification of eight new clerodane diterpenes [anacolosins A-F (1-6) and corymbulosins X and Y (7 and 8)] and two known compounds (9 and 10) that contained an isozuelanin skeleton. The structures of the new natural products were determined using 1D and 2D NMR and HRESIMS data, while the relative and absolute configurations of the compounds were assessed using a combination of H NMR coupling constant data, ROESY experiments, ECD (electronic circular dichroism) and VCD (vibrational circular dichroism) spectroscopy, chemical methods (including Mosher and 2-naphthacyl esterification), and chiral HPLC analyses. Read More

View Article

Download full-text PDF

Source
http://pubs.acs.org/doi/10.1021/acs.jnatprod.8b01015
Publisher Site
http://dx.doi.org/10.1021/acs.jnatprod.8b01015DOI Listing
March 2019
5 Reads

Clinical outcomes after major hepatectomy are acceptable in low-volume centers in the Caribbean.

World J Hepatol 2019 Feb;11(2):199-207

Department of Clinical Surgical Sciences, University of the West Indies, St. Augustine, Trinidad and Tobago 999183, West Indies.

Background: Major hepatectomies are routinely performed because they are often the only curative treatment for metastatic liver disease. There has been a trend to concentrate major hepatectomies in referral hospitals that perform these operations at high volumes. These high volume referral centers are usually located in developed countries, but many patients in developing nations are not able to access these centers because of financial limitations, lack of social support and/or travel restrictions. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4254/wjh.v11.i2.199DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393710PMC
February 2019
3 Reads

Multifocal hepatoblastoma: What is the risk of recurrent disease in the remnant liver?

J Pediatr Surg 2019 Feb 2. Epub 2019 Feb 2.

Division of General and Thoracic Surgery, Hospital for Sick Children, University of Toronto, Toronto, Canada.

Purpose: Multifocal hepatoblastoma (HB) is often treated with total hepatectomy and transplantation owing to concerns of surgical resectability, local recurrence, and/or metachronous tumor in the remnant liver. We aimed to review HB patients to determine the risk of local recurrence in multifocal disease.

Methods: We undertook retrospective cohort analysis of all HB patients at a single tertiary referral center between 2001 and 2015. Read More

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00223468193007
Publisher Site
http://dx.doi.org/10.1016/j.jpedsurg.2019.01.036DOI Listing
February 2019
4 Reads

Hepatoblastoma and Wilms' tumour in an infant with Beckwith-Wiedemann syndrome and diazoxide resistant congenital hyperinsulinism.

Endocrinol Diabetes Metab Case Rep 2019 Feb 27;2019. Epub 2019 Feb 27.

Departments of Paediatric Endocrinology, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.

Beckwith-Wiedemann syndrome (BWS) can be associated with embryonal tumours and congenital hyperinsulinism (CHI). We present an infant with BWS who developed congenital hepatoblastoma and Wilms' tumour during infancy. The infant presented with recurrent hypoglycaemia requiring high intravenous glucose infusion and was biochemically confirmed to have CHI. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EDM-18-0146DOI Listing
February 2019
3 Reads

Correlation between hepatic oxidative damage and clinical severity and mitochondrial gene sequencing results in biliary atresia.

Hepatol Res 2019 Feb 27. Epub 2019 Feb 27.

Department of Pediatric Surgery, Children's Hospital of Fudan University, Shanghai, China.

Aim: To assess the level of hepatic oxidative damage and its correlation with clinical severity in biliary atresia (BA), and to understand BA mitochondrial gene sequencing.

Methods: Forty-eight BA patients and 28 control subjects (20 hepatoblastoma and 8 cholestasis patients) were enrolled. Hepatic oxidative damage was assessed by the expression of oxidation and antioxidant genes, and the correlation between oxidative damage and BA incidence, liver inflammation, and fibrosis was evaluated. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/hepr.13324DOI Listing
February 2019
3 Reads

CircHMGCS1 Promotes Hepatoblastoma Cell Proliferation by Regulating the IGF Signaling Pathway and Glutaminolysis.

Theranostics 2019 25;9(3):900-919. Epub 2019 Jan 25.

Department of Clinical Laboratory Medicine, Shanghai Children's Medical Center, School of medicine, Shanghai Jiaotong University, Shanghai, 200127, China.

Circular RNAs (circRNAs), a novel class of endogenous RNAs, have been recently shown to participate in cellular development and several pathophysiological processes. The identification of dysregulated circRNAs and their function in cancer have attracted considerable attention. Nevertheless, the expression profile and role of circRNAs in human hepatoblastoma (HB) remain to be studied. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.7150/thno.29515DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6376477PMC
January 2019
1 Read

Surgical and anesthetic management for hepatectomy in two pediatric patients with trisomy 18, pulmonary hypertension, and hepatoblastoma.

Pediatr Blood Cancer 2019 Jun 25;66(6):e27678. Epub 2019 Feb 25.

Division of Pediatric Hematology/Oncology, Providence Sacred Heart Children's Hospital, Spokane, Washington.

Children with trisomy 18 are surviving longer and undergoing more aggressive life-sustaining therapy. This report describes two patients with trisomy 18 and hepatoblastoma (HB) successfully resected in the setting of significant pulmonary hypertension. Forty-four previously published cases of the association between HB and trisomy 18 are reviewed. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/pbc.27678DOI Listing

β-Catenin and Yes-Associated Protein 1 Cooperate in Hepatoblastoma Pathogenesis.

Am J Pathol 2019 Feb 19. Epub 2019 Feb 19.

Department of Gynecology, Shiyan Taihe Hospital, Affiliated Hospital of Hubei University of Medicine, Shiyan, China. Electronic address:

Hepatoblastoma (HB), the most common pediatric primary liver neoplasm, shows nuclear localization of β-catenin and yes-associated protein 1 (YAP1) in almost 80% of the cases. Coexpression of constitutively active S127A-YAP1 and ΔN90 deletion-mutant β-catenin (YAP1-ΔN90-β-catenin) causes HB in mice. Because heterogeneity in downstream signaling is being identified owing to mutational differences even in the β-catenin gene alone, we investigated if co-expression of point mutants of β-catenin (S33Y or S45Y) with S127A-YAP1 led to similar tumors as YAP1-ΔN90-β-catenin. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2019.02.002DOI Listing
February 2019
4 Reads

TEA Domain Transcription Factor 4 Is the Major Mediator of Yes-Associated Protein Oncogenic Activity in Mouse and Human Hepatoblastoma.

Am J Pathol 2019 Feb 19. Epub 2019 Feb 19.

Department of Bioengineering and Therapeutic Sciences and Liver Center, University of California, San Francisco, San Francisco, California. Electronic address:

Hepatoblastoma (HB) is the most common type of pediatric liver cancer. Activation of yes-associated protein (YAP) has been implicated in HB molecular pathogenesis. The transcriptional co-activator Yap regulates downstream gene expression through interaction with the TEA domain (TEAD) proteins. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ajpath.2019.01.016DOI Listing
February 2019
2 Reads
4.591 Impact Factor

Problematic lesions in cirrhotic liver mimicking hepatocellular carcinoma.

Eur Radiol 2019 Feb 20. Epub 2019 Feb 20.

Department of Radiology, Research Institute of Radiological Science, Severance Hospital, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodaemun-gu, Seoul, 03722, South Korea.

Hepatocellular carcinoma (HCC) is a unique malignancy that can be diagnosed and treated based on non-invasive imaging criteria without histological confirmation in cirrhotic patients, which opens the possibility, although rare, of false-positive diagnosis of the tumor. This brief review illustrates benign and non-HCC malignant lesions arising in cirrhotic liver that could have been erroneously diagnosed as HCC based on imaging criteria: focal nodular hyperplasia-like nodules, serum amyloid A-positive nodules, dysplastic nodules, spontaneously regressing lesions, combined hepatocellular-cholangiocarcinoma, cholangiocarcinoma, sarcomatoid carcinoma, lymphoepithelioma-like carcinoma, hepatoblastoma, and metastatic adenocarcinoma. To determine the potential differences in clinical courses and post-treatment outcome of HCC diagnosed by imaging alone and those histologically, we suggest the terms HCCi and HCCp to distinguish between lesions that are diagnosed as HCC based on imaging alone from those diagnosed based on pathological examination, respectively. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00330-019-06030-0DOI Listing
February 2019
2 Reads

Defining and listing very rare cancers of paediatric age: consensus of the Joint Action on Rare Cancers in cooperation with the European Cooperative Study Group for Pediatric Rare Tumors.

Eur J Cancer 2019 Mar 19;110:120-126. Epub 2019 Feb 19.

Department of Epidemiological Research and Molecular Medicine, Evaluative Epidemiology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Italy. Electronic address:

Although all tumours are rare in childhood, there are some particularly rare paediatric cancers which have not benefited from advances made by the international paediatric oncology network. To establish a shared definition and produce a list of these entities, the European Union Joint Action on Rare Cancers (JARC) promoted a consensus effort. The definition was based on the incidence rates estimated using the information network on rare cancers (RARECAREnet) database, pooling data from 94 population-based cancer registries and 27 countries. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ejca.2018.12.031DOI Listing
March 2019
5.417 Impact Factor

Navigation surgery using indocyanine green fluorescent imaging for hepatoblastoma patients.

Pediatr Surg Int 2019 May 16;35(5):551-557. Epub 2019 Feb 16.

Department of Pediatric Surgery, Graduate School of Medical Sciences, Kyushu University, 3-1-1 Maidashi, Higashi-ku, Fukuoka, 812-8582, Japan.

Background: Technology for detecting liver tumors and identifying the bile ducts using indocyanine green (ICG) has recently been developed. However, the usefulness and limitations of ICG navigation surgery for hepatoblastoma (HB) have not been fully clarified. We herein report our experiences with surgical navigation using ICG for in HB patients. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00383-019-04458-5DOI Listing
May 2019
2 Reads

The Pediatric Surgical Team: a Model for Increased Surgeon Index Case Exposure.

J Pediatr Surg 2019 Jan 21. Epub 2019 Jan 21.

Kapi'olani Medical Center for Children, 1319 Punahou St., Honolulu, HI, USA 96826.

Background/purpose: High surgical volume for both surgeons and hospital systems has been linked to improved outcomes for many surgical problems, yet case volumes per pediatric surgeon are diminishing nationally in complex pediatric surgery. We therefore sought to review our experience in a geographically isolated setting where a surgical team approach has been used to improve per-surgeon exposure to index pediatric surgical cases.

Methods: As a surgical group, we incorporated a surgical team approach to complex pediatric surgical cases in 2010. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpedsurg.2018.12.018DOI Listing
January 2019
1 Read

Contemporary management of hepatoblastoma.

Curr Opin Organ Transplant 2019 Apr;24(2):113-117

Division of Hepatobiliary Surgery and Liver Transplantation, Department of Surgery, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

Purpose Of Review: Hepatoblastoma is the most common primary pediatric liver malignancy. The goal of treatment in hepatoblastoma is complete surgical resection. Recently published multinational collaborative studies are better defining risk factors for disease recurrence and guide optimal treatment strategy. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/MOT.0000000000000618DOI Listing
April 2019
4 Reads

Indications and efficacy of conversion from tacrolimus- to sirolimus-based immunosuppression in pediatric patients who underwent liver transplantation for unresectable hepatoblastoma.

Pediatr Transplant 2019 Feb 4:e13369. Epub 2019 Feb 4.

Department of Surgery, Children's Mercy Hospital, Kansas City, Missouri.

SRL-based immunosuppressive strategies in pediatric liver transplantation are not clearly defined, especially within the first year after liver transplant. TAC is the more common, traditional immunosuppressant used. However, SRL may modulate TAC-associated kidney injury and may also have antiproliferative properties that are valuable in the management of patients following liver transplantation for HB. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1111/petr.13369DOI Listing
February 2019
3 Reads

Metformin attenuates hypoxia-induced resistance to cisplatin in the HepG2 cell line.

Oncol Lett 2019 Feb 24;17(2):2431-2440. Epub 2018 Dec 24.

Department of Radiology and Radiation Oncology, Hirosaki University Graduate School of Medicine, Hirosaki, Aomori 036-8562, Japan.

Hepatoblastoma is the most commonly occurring liver tumor in children. Preoperative chemotherapy and surgery have improved treatment outcomes; however, further improvements are required in the treatment of advanced cases. Recently, the efficacy of transarterial chemoembolization (TACE) has garnered attention. Read More

View Article

Download full-text PDF

Source
http://www.spandidos-publications.com/10.3892/ol.2018.9869
Publisher Site
http://dx.doi.org/10.3892/ol.2018.9869DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6350205PMC
February 2019
4 Reads

Hepatoblastoma with Precocious Puberty.

J Indian Assoc Pediatr Surg 2019 Jan-Mar;24(1):68-71

Department of Pediatric Surgery, Postgraduate Institute of Medical Education and Research, Chandigarh, India.

Hepatoblastoma (HB), a primary liver tumor of childhood, is often accompanied by raised levels of alpha-fetoprotein (α-FP). Rarely, the beta-human chorionic gonadotropin (β-hCG) levels may also be elevated, which can cause peripheral precocious puberty (PPP). We report a case of HB with precocious puberty wherein hormonal assays showed an increase in α-FP, β-hCG, and testosterone levels, and suppression of follicle-stimulating and luteinizing hormone levels. Read More

View Article

Download full-text PDF

Source
http://www.jiaps.com/text.asp?2019/24/1/68/247897
Publisher Site
http://dx.doi.org/10.4103/jiaps.JIAPS_102_18DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6322182PMC
January 2019
4 Reads

JTC-801 inhibits the proliferation and metastasis of the Hep G2 hepatoblastoma cell line by regulating the phosphatidylinositol 3-kinase/protein kinase B signalling pathway.

Authors:
Bufei Zhao Ting Hu

Oncol Lett 2019 Feb 30;17(2):1939-1945. Epub 2018 Nov 30.

Department of Oncology, The First Affiliated Hospital of Changchun University of Chinese Medicine, Changchun, Jilin 130021, P.R. China.

The increased worldwide mortality rate due to liver cancer may be attributed to the aggressive nature of the disease. Signal transduction through G-protein-coupled receptors (GPCRs) can affect a number of aspects of cancer biology, including invasion, migration and vascular remodelling. JTC-801, a novel GPCR antagonist, has demonstrated promising anticancer effects in adenocarcinoma and osteosarcoma cells. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/ol.2018.9780DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341900PMC
February 2019

Expression of flTF and asTF splice variants in various cell strains and tissues.

Mol Med Rep 2019 Mar 10;19(3):2077-2086. Epub 2019 Jan 10.

Division of Clinical Chemistry and Pharmacology, Department of Laboratory Medicine, Lund University Hospital, S‑221 85 Lund, Sweden.

Tissue factor (TF) expressed at the protein level includes two isoforms: The membrane‑bound full‑length TF (flTF) and the soluble alternatively spliced TF (asTF). flTF is the major thrombogenic form of TF, whereas asTF is more closely associated with tumor growth, angiogenesis, metastasis and cell growth. In order to further investigate the different expression and functions of TF splice variants, the expression of these two splice variants were detected in numerous cell strains and tissues in the present study. Read More

View Article

Download full-text PDF

Source
http://dx.doi.org/10.3892/mmr.2019.9843DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6390075PMC
March 2019
3 Reads